Yong Wu

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 11

Top Venues

Mediators of inflammation

Cancer communications (London, England)

Breast cancer research : BCR

Science advances

Charles Drew University of Medicine and Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charles Drew University of Medicine and Science

United States

Assistant Professor :: Internal Medicine

Publications

Dingxie Liu, Qiongyu Hao, Jieqing Li, Qun Li, Kun Wang, Qing Geng, Yutong Wu, Jaydutt V Vadgama, Yong Wu
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients. Cancer communications (London, England) 42 (7) (2022)
Qiongyu Hao, Zhimin Huang, Qun Li, Dingxie Liu, Piwen Wang, Kun Wang, Jieqing Li, Wei Cao, Wenhong Deng, Ke Wu, Rui Su, Zhongmin Liu, Jay Vadgama, Yong Wu
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes-Associated Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (6) (2022)
Dingxie Liu, Yong Wu
Association of an anaplastic lymphoma kinase pathway signature with cell de-differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer. Cancer communications (London, England) 40 (9) (2020)
Qiongyu Hao, Piwen Wang, Pranabananda Dutta, Seyung Chung, Qun Li, Kun Wang, Jieqing Li, Wei Cao, Wenhong Deng, Qing Geng, Katrina Schrode, Magda Shaheen, Ke Wu, Donghui Zhu, Qiao-Hong Chen, Guanglin Chen, Yahya Elshimali, Jay Vadgama, Yong Wu
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA. Cell death & disease 11 (12) (2020)
Qun Li, Qiongyu Hao, Wei Cao, Jieqing Li, Ke Wu, Yahya Elshimali, Donghui Zhu, Qiao-Hong Chen, Guanglin Chen, Jonathan R Pollack, Jaydutt V Vadgama, Yong Wu
PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Science advances 5 (10) (2019)
Wei Cao, Jieqing Li, Qiongyu Hao, Jaydutt V Vadgama, Yong Wu
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. Breast cancer research : BCR 21 (1) (2019)
Seyung S Chung, Yong Wu, Quincy Okobi, Debbie Adekoya, Mohammad Atefi, Orette Clarke, Pranabananda Dutta, Jaydutt V Vadgama
Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells. Mediators of inflammation 2017 (2017)
Yong Wu, Yunzhou Dong, Shengzhong Duan, Donghui Zhu, Lin Deng
Metabolic Syndrome, Inflammation, and Cancer. Mediators of inflammation 2017 (2017)
Yunzhou Dong, Yong Wu, Mei-Zhen Cui, Xuemin Xu
Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21. Mediators of inflammation 2017 (2017)
Yong Wu, Yunzhou Dong, Shengzhong Duan, Donghui Zhu, Lin Deng
Corrigendum to "Metabolic Syndrome, Inflammation, and Cancer". Mediators of inflammation 2017 (2017)
Yong Wu, Yunzhou Dong, Mohammad Atefi, Yanjun Liu, Yahya Elshimali, Jaydutt V Vadgama
Lactate, a Neglected Factor for Diabetes and Cancer Interaction. Mediators of inflammation 2016 (2016)

Yong Wu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yong Wu